• 1. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 2. An approach towards the synthesis of novel fused nitrogen tricyclic heterocyclic scaffolds via GBB reaction?
  Sandip Gangadhar Balwe,Yeon Tae Jeong Org. Biomol. Chem., 2018,16, 1287-1296
• 3. An intermolecular C–H oxidizing strategy to access highly fused carbazole skeletons from simple naphthylamines?
  Christian K. Rank,Alexander W. Jones,Tatjana Wall,Patrick Di Martino-Fumo,Sarah Schr?ck,Markus Gerhards,Frederic W. Patureau Chem. Commun., 2019,55, 13749-13752
• 4. An antimonate pyrochlore (H1.23Sr0.45SbO3.48) for photocatalytic oxidation of benzene: effective oxygen usage and excellent activity?
  Jing Chen,Yu Shao,Danzhen Li J. Mater. Chem. A, 2017,5, 937-941
• 5. An aquatic host–guest complex between a supramolecular G-quadruplex and the anticancer drug doxorubicin?
  José M. Rivera,Mariana Martín-Hidalgo,Jean C. Rivera-Ríos Org. Biomol. Chem., 2012,10, 7562-7565

• Solvents and Organic Chemicals Organic Compounds Benzenoids Phenol ethers Anisoles

Recent Advances in the Study of 2-amino-1-(2-methoxy-5-methylphenyl)ethan-1-ol (CAS: 100131-97-3)

The compound 2-amino-1-(2-methoxy-5-methylphenyl)ethan-1-ol (CAS: 100131-97-3) has recently garnered significant attention in the field of chemical biology and pharmaceutical research. This molecule, characterized by its unique structural features, has shown promising potential in various therapeutic applications. Recent studies have focused on elucidating its pharmacological properties, synthetic pathways, and potential as a lead compound in drug discovery.

One of the key areas of investigation has been the compound's role as a precursor or intermediate in the synthesis of more complex bioactive molecules. Researchers have explored its utility in the development of novel adrenergic receptor modulators, given its structural resemblance to known adrenergic agonists. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that derivatives of 2-amino-1-(2-methoxy-5-methylphenyl)ethan-1-ol exhibit selective binding to β2-adrenergic receptors, suggesting potential applications in the treatment of respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD).

Another significant development involves the compound's potential neuroprotective effects. Preliminary in vitro studies have indicated that 2-amino-1-(2-methoxy-5-methylphenyl)ethan-1-ol may modulate oxidative stress pathways in neuronal cells, offering a possible avenue for the treatment of neurodegenerative diseases. These findings were recently presented at the 2024 International Conference on Chemical Biology and remain under further investigation.

From a synthetic chemistry perspective, recent advancements have been made in optimizing the production of 2-amino-1-(2-methoxy-5-methylphenyl)ethan-1-ol. A team at the University of Cambridge developed a novel catalytic asymmetric synthesis method that improves both the yield and enantiomeric purity of the compound, as detailed in their 2023 publication in Angewandte Chemie. This breakthrough has important implications for scaling up production while maintaining the high purity required for pharmaceutical applications.

Pharmacokinetic studies of 2-amino-1-(2-methoxy-5-methylphenyl)ethan-1-ol have also progressed significantly. Recent animal model studies have provided valuable data on the compound's absorption, distribution, metabolism, and excretion (ADME) profile. These studies, conducted by a collaborative team from several pharmaceutical companies, suggest that the molecule has favorable bioavailability and metabolic stability characteristics, though further optimization may be required to improve its blood-brain barrier penetration for potential CNS applications.

Looking forward, researchers anticipate that 2-amino-1-(2-methoxy-5-methylphenyl)ethan-1-ol and its derivatives will continue to be an area of active investigation. Current research directions include exploring its potential as a scaffold for developing new antimicrobial agents, as well as investigating its possible anti-inflammatory properties. The compound's versatility and the recent methodological advances in its synthesis and modification suggest it will remain an important focus of chemical biology research in the coming years.

• 3600-87-1(ST 1059(Desglymidodrine))
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)